1. Attributes influencing parental decision-making to receive the Tdap vaccine to reduce the risk of pertussis transmission to their newborn – outcome of a cross-sectional conjoint experiment in Spain and Italy. Issue 5 (4th May 2019) Authors: Ledent, Edouard; Gabutti, Giovanni; de Bekker-Grob, Esther W.; Alcázar Zambrano, Juan Luis; Campins Martí, Magda; Del Hierro Gurruchaga, María Teresa; Fernández Cruz, María José; Ferrera, Giuseppe; Fortunato, Francesca; Torchio, Pierfederico; Zoppi, Giorgio; Agboton, Christian; Kandeil, Walid; Ma... Journal: Human vaccines & immunotherapeutics Issue: Volume 15:Issue 5(2019) Page Start: 1080 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Biosimilars in chronic inflammatory diseases: facts and remaining questions 5 years after their introduction in Europe. (1st February 2022) Authors: Agboton, Christian; Salameh, Joseph Journal: Expert opinion on biological therapy Issue: Volume 22:Number 2(2022) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the VISIBLE 2 Randomised Trial. (17th August 2021) Authors: Vermeire, Séverine; D'Haens, Geert; Baert, Filip; Danese, Silvio; Kobayashi, Taku; Loftus, Edward V; Bhatia, Siddharth; Agboton, Christian; Rosario, Maria; Chen, Chunlin; Zhang, Wenwen; Kisfalvi, Krisztina; Sandborn, William J Journal: Journal of Crohn's and colitis Issue: Volume 16:Number 1(2022) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Integrating efficacy and safety of vedolizumab compared with other advanced therapies to assess net clinical benefit of ulcerative colitis treatments: a network meta-analysis. (3rd June 2021) Authors: Jairath, Vipul; Chan, Keith; Lasch, Karen; Keeping, Sam; Agboton, Christian; Blake, Aimee; Patel, Haridarshan Journal: Expert review of gastroenterology & hepatology Issue: Volume 15:Number 6(2021) Page Start: 711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Measuring Serum Vedolizumab and Antibodies to Vedolizumab: Comparison of Four Commercially Available Clinical Laboratory Assays to the Assay Used in Vedolizumab Development: 675. (October 2019) Authors: Yang, Lili; Dobler, Iwona; Agboton, Christian; Osborn, Teresa; Smithson, Glennda Journal: American journal of gastroenterology Issue: Volume 114 (2019)ACG Abstracts 1:Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Measuring Serum Vedolizumab and Vedolizumab Antibodies: Comparison of Commercial Assays with the Vedolizumab Clinical Development Assay. Issue 2 (15th April 2023) Authors: Vande Casteele, Niels; Yang, Lili; Dobler, Iwona; Agboton, Christian; McRorie Osborn, Teresa; Suri, Ajit; Lindner, Dirk; Smithson, Glennda M. Journal: Therapeutic drug monitoring Issue: Volume 45:Issue 2(2023) Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P038 Comparing the Efficacy and Safety of Subcutaneous Vedolizumab Versus Adalimumab for the Treatment of Ulcerative Colitis: A Network Meta-Analysis. (December 2019) Authors: Jairath, Vipul; Chan, Keith; Lasch, Karen; Keeping, Sam; Agboton, Christian; Blake, Aimee; Jansen, Jeroen; Patel, Haridarshan Journal: American journal of gastroenterology Issue: Volume 114:2019 Supplement (2019)Abstracts 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P039 Integrating Maintenance Efficacy and Safety of Vedolizumab and Other Advanced Therapies for the Treatment of Ulcerative Colitis: A Network Meta-Analysis. (December 2019) Authors: Jairath, Vipul; Chan, Keith; Lasch, Karen; Keeping, Sam; Agboton, Christian; Blake, Aimee; Jansen, Jeroen; Patel, Haridarshan Journal: American journal of gastroenterology Issue: Volume 114:2019 Supplement (2019)Abstracts 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Real‐world multicentre observational study including population pharmacokinetic modelling to evaluate the exposure–response relationship of vedolizumab in inflammatory bowel disease: ERELATE Study. Issue 3 (27th April 2022) Authors: Vande Casteele, Niels; Sandborn, William J.; Feagan, Brian G.; Vermeire, Séverine; Dulai, Parambir S.; Yarur, Andres; Roblin, Xavier; Ben‐Horin, Shomron; Dotan, Iris; Osterman, Mark T.; Rosario, Maria; Osborn, Teresa McRorie; Panes, Julian; Lindner, Dirk; Agboton, Christian Journal: Alimentary pharmacology & therapeutics Issue: Volume 56:Issue 3(2022) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. S0652 Real World Exposure-Response Relationship of Vedolizumab in Inflammatory Bowel Disease: A Pooled Multicenter Observational Cohort Analysis of Clinical and Modeled Pharmacological Data. (October 2020) Authors: Casteele, Niels Vande; Sandborn, William J.; Feagan, Brian G.; Vermeire, Séverine; Dulai, Parambir S.; Panés, Julian; Yarur, Andres; Roblin, Xavier; Ben-Horin, Shomron; Dotan, Iris; Osterman, Mark; Lindner, Dirk; Agboton, Christian; Rosario, Maria; Osborn, Teresa Journal: American journal of gastroenterology Issue: Volume 115:Supplement(2020)ACG Annual Meeting Abstracts 1 Page Start: S326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗